Wagner, Laura https://orcid.org/0000-0002-5184-8154
Schneider, Heike
Luppa, Peter B.
Schröder, Kathrin
Wantia, Nina
Querbach, Christiane
Jeske, Samuel D.
Lahmer, Tobias
Rothe, Kathrin
Dibos, Miriam
Voit, Florian
Erber, Johanna
Spinner, Christoph D.
Schneider, Jochen
Triebelhorn, Julian
Funding for this research was provided by:
Technische Universität München
Article History
Received: 27 April 2024
Accepted: 27 August 2024
First Online: 9 September 2024
Declarations
:
: The authors declare no competing interests. CDS received grants and personal fees from AbbVie; grants, fees, and non-financial support from Gilead Sciences; grants and personal fees from Janssen-Cilag; grants and personal fees from MSD; grants from Cepheid; personal fees from GSK; grants and personal fees from ViiV Healthcare, during the conduct of the study; fees from AstraZeneca and Apeiron; grants, personal fees, and non-financial support from B. Braun Melsungen; grants and personal fees from BioNtech; personal fees from Eli Lilly, Formycon, Moderna, Molecular partners, Novartis, Roche, SOBI, Shionogi, and Pfizer; and grants and personal fees from Eli Lilly. JE received non-financial support from Gilead Sciences, ViiV Healthcare, and Pfizer. FV received personal fees and non-financial support from Gilead Sciences and ViiV Healthcare and grants from MSD and B. Braun Melsungen AG outside of the submitted work.